{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:19:37Z","timestamp":1791659977948,"version":"4.3.4"},"reference-count":148,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.npep.2010.12.002","type":"journal-article","created":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T09:24:11Z","timestamp":1296120251000},"page":"93-104","source":"Crossref","is-referenced-by-count":115,"title":["Calcitonin gene-related peptide (CGRP) and its role in hypertension"],"prefix":"10.1016","volume":"45","author":[{"given":"Sarah-Jane","family":"Smillie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan D.","family":"Brain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2010.12.002_b0005","doi-asserted-by":"crossref","first-page":"11325","DOI":"10.1074\/jbc.271.19.11325","article-title":"A cDNA encoding the calcitonin gene-related peptide type 1 receptor","volume":"271","author":"Aiyar","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2010.12.002_b0010","unstructured":"Alevizaki, M., Shiraishi, A., Rassool, F.V., Ferrier, G.J., MacIntyre, I., Legon, S. 1986.The calcitonin-like sequence of the beta CGRP gene. FEBS Lett. 206, 47\u201352."},{"key":"10.1016\/j.npep.2010.12.002_b0015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/298240a0","article-title":"Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products","volume":"298","author":"Amara","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.npep.2010.12.002_b0020","first-page":"R425","article-title":"Hemodynamic effects of calcitonin gene-related peptide in spontaneously hypertensive rats","volume":"258","author":"Ando","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.npep.2010.12.002_b0025","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/sj.bjp.0701986","article-title":"Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: effect of insulin and nerve growth factor","volume":"124","author":"Bennett","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/01.HYP.0000168926.44648.ed","article-title":"Role of calcitonin gene-related peptide in hypertension-induced renal damage","volume":"46","author":"Bowers","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.npep.2010.12.002_b0035","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1476-5381.1985.tb11107.x","article-title":"Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability","volume":"86","author":"Brain","year":"1985","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0040","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/1523-1747.ep12455620","article-title":"Potent vasodilator activity of calcitonin gene-related peptide in human skin","volume":"87","author":"Brain","year":"1986","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.npep.2010.12.002_b0045","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1152\/physrev.00037.2003","article-title":"Vascular actions of calcitonin gene-related peptide and adrenomedullin","volume":"84","author":"Brain","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.npep.2010.12.002_b0050","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/sj.bjp.0706461","article-title":"Neuropeptides and their receptors: innovative science providing novel therapeutic targets","volume":"147","author":"Brain","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0055","unstructured":"Branca, F., Nikogosian, H., Lobstein, T. 2007. The challenge of obesity in the WHO European Region and the Strategies for Response."},{"key":"10.1016\/j.npep.2010.12.002_b0060","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0014-5793(00)02259-6","article-title":"Glycosylation of the calcitonin receptor-like receptor at Asn(60) or Asn(112) is important for cell surface expression","volume":"486","author":"B\u00fchlmann","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.npep.2010.12.002_b0065","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0165-1838(94)90009-4","article-title":"Intrathecal capsaicin enhances one-kidney renal wrap hypertension in the rat","volume":"50","author":"Burg","year":"1994","journal-title":"J. Auton. Nerv. Syst."},{"key":"10.1016\/j.npep.2010.12.002_b0070","doi-asserted-by":"crossref","first-page":"8317","DOI":"10.1021\/bi0102860","article-title":"Turn structures in CGRP C-terminal analogues promote stable arrangements of key residue side chains","volume":"40","author":"Carpenter","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.npep.2010.12.002_b0075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejphar.2005.12.039","article-title":"The role of calcitonin gene-related peptide (CGRP) in ischemic preconditioning in isolated rat hearts","volume":"531","author":"Chai","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0080","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/jpet.110.165993","article-title":"Characterization of the CGRP receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries","volume":"334","author":"Chan","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2010.12.002_b0085","first-page":"E331","article-title":"Calcitonin gene-related peptide receptor antagonist human CGRP-(8\u201337)","volume":"256","author":"Chiba","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.npep.2010.12.002_b0090","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1042\/bst0300451","article-title":"Interaction of calcitonin-gene-related peptide with its receptors","volume":"30","author":"Conner","year":"2002","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.npep.2010.12.002_b0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1476-5381.1990.tb14656.x","article-title":"Action of calcitonin gene-related peptide upon bovine vascular endothelial and smooth muscle cells grown in isolation and co-culture","volume":"99","author":"Crossman","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0100","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.peptides.2005.02.002","article-title":"Calcitonin gene-related peptide and hypertension","volume":"26","author":"Deng","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2010.12.002_b0105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-3565(25)12587-1","article-title":"HCGRP8\u201337, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery","volume":"254","author":"Dennis","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2010.12.002_b0110","doi-asserted-by":"crossref","first-page":"F1427","DOI":"10.1152\/ajprenal.90599.2008","article-title":"Do distinct populations of dorsal root ganglion neurons account for the sensory peptidergic innervation of the kidney? Am","volume":"297","author":"Ditting","year":"2009","journal-title":"J. Physiol. Renal Physiol."},{"key":"10.1016\/j.npep.2010.12.002_b0115","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S1885-5857(09)72223-6","article-title":"Alcohol consumption and risk of hypertension: does the type of beverage or drinking pattern matter?","volume":"62","author":"Djouss\u00e9","year":"2009","journal-title":"Revista Espa\u00f1ola De Cardiolog\u00eda"},{"key":"10.1016\/j.npep.2010.12.002_b0120","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/sj.bjp.0703110","article-title":"Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist","volume":"129","author":"Doods","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0125","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(10)60323-6","article-title":"New drugs in migraine treatment and prophylaxis: telcagepant and topiramate","volume":"376","author":"Edvinsson","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.npep.2010.12.002_b0130","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1177\/0333102410362122","article-title":"Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries","volume":"30","author":"Edvinsson","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.npep.2010.12.002_b0135","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/CS20050016","article-title":"Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect","volume":"109","author":"Edvinsson","year":"2005","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.npep.2010.12.002_b0140","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0196-9781(98)00066-7","article-title":"Innervation of the human middle meningeal artery: Immunohistochemistry, ultrastructure, and role of endothelium for vasomotility","volume":"19","author":"Edvinsson","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2010.12.002_b0145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/08037059209077667","article-title":"Sensory nerve activity in sever hypertension as reflected by circulating calcitonin gene-related peptide (CGRP) and substance P","volume":"1","author":"Edvinsson","year":"1992","journal-title":"Blood Press."},{"key":"10.1016\/j.npep.2010.12.002_b0150","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00004872-198900076-00093","article-title":"Circulating perivascular dilatory neuropeptides in hypertension","volume":"7","author":"Edvinsson","year":"1989","journal-title":"J. Hypertens."},{"key":"10.1016\/j.npep.2010.12.002_b0155","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-3940(85)90166-1","article-title":"Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat","volume":"58","author":"Edvinsson","year":"1985","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2010.12.002_b0160","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1161\/01.ATV.0000217611.81085.c5","article-title":"Endothelium-derived hyperpolarizing factor: where are we now?","volume":"26","author":"F\u00e9l\u00e9tou","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.npep.2010.12.002_b0165","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/978-3-540-79090-7_11","article-title":"Sensory-nerve-derived neuropeptides: possible therapeutic targets","volume":"194","author":"Fernandes","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0170","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/305534a0","article-title":"Stimulation of noradrenergic sympathetic outflow by calcitonin gene- related peptide","volume":"305","author":"Fisher","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.npep.2010.12.002_b0175","doi-asserted-by":"crossref","first-page":"10333","DOI":"10.1021\/bi0347508","article-title":"N-glycosylation and conserved cysteine residues in RAMP3 play a critical role for the functional expression of CLR\/RAMP3 adrenomedullin receptor","volume":"42","author":"Flahaut","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.npep.2010.12.002_b0180","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/bbrc.1995.1047","article-title":"A human orphan calcitonin receptor-like structure","volume":"206","author":"Fluhmann","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.npep.2010.12.002_b0185","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1124\/mol.55.6.1054","article-title":"The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor","volume":"55","author":"Fraser","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0190","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1751-7176.2009.00123.x","article-title":"Is surgery the next answer to treat obesity-related hypertension?","volume":"11","author":"Frezza","year":"2009","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.npep.2010.12.002_b0195","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"27","author":"Furchgott","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.npep.2010.12.002_b0200","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.HYP.35.1.470","article-title":"Increased Blood Pressure in\u03b1-Calcitonin Gene\u2013Related Peptide\/Calcitonin Gene Knockout Mice","volume":"35","author":"Gangula","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.npep.2010.12.002_b0205","doi-asserted-by":"crossref","first-page":"H284","DOI":"10.1152\/ajpheart.1999.276.1.H284","article-title":"Pregnancy and steroid hormones enhance the vasodilation responses to CGRP in rats","volume":"276","author":"Gangula","year":"1999","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"10.1016\/j.npep.2010.12.002_b0210","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.HYP.29.1.248","article-title":"Calcitonin gene-related peptide is a depressor in NG-nitro-L-arginine methyl ester-induced hypertension during pregnancy","volume":"29","author":"Gangula","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.npep.2010.12.002_b0215","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2337\/diabetes.40.8.948","article-title":"Antagonistic effect of human alpha-calcitonin gene-related peptide (8\u201337) on regional hemodynamic actions of rat islet amyloid polypeptide in conscious Long-Evans rats","volume":"40","author":"Gardiner","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.npep.2010.12.002_b0220","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF02554909","article-title":"Cardiovascular action of calcitonin gene-related peptide in humans","volume":"37","author":"Gennari","year":"1985","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.npep.2010.12.002_b0225","series-title":"Neurogenic Inflammation","author":"Geppetti","year":"1996"},{"key":"10.1016\/j.npep.2010.12.002_b0230","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/brain\/117.3.427","article-title":"Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies","volume":"117","author":"Goadsby","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.npep.2010.12.002_b0235","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410330109","article-title":"The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats","volume":"33","author":"Goadsby","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.npep.2010.12.002_b0240","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","article-title":"Vasoactive peptide release in the extracerebral circulation of humans during migraine headache","volume":"28","author":"Goadsby","year":"1990","journal-title":"Ann. Nerol."},{"key":"10.1016\/j.npep.2010.12.002_b0245","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410230214","article-title":"Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system","volume":"23","author":"Goadsby","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.npep.2010.12.002_b0250","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/0024-3205(86)90568-0","article-title":"Calcitonin gene-related peptide: novel neuropeptide","volume":"38","author":"Goodman","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2010.12.002_b0255","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1021\/bi002497v","article-title":"Mutations of the asparagine117 residue of a receptor activity-modifying protein 1-dependent human calcitonin gene-related peptide receptor result in selective loss of function","volume":"40","author":"Gujer","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.npep.2010.12.002_b0740","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/13697130802378493","article-title":"Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implications for insulin resistance and cardiovascular risks","volume":"11","author":"Gupta","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.npep.2010.12.002_b0260","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(05)67483-1","article-title":"Obesity","volume":"366","author":"Haslam","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.npep.2010.12.002_b0265","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1440-1681.2007.04703.x","article-title":"What makes a CGRP2 receptor?","volume":"34","author":"Hay","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.npep.2010.12.002_b0270","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1385\/JMN:22:1-2:105","article-title":"The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors","volume":"22","author":"Hay","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.npep.2010.12.002_b0275","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BFb0033194","article-title":"Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds","volume":"121","author":"Holzer","year":"1992","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0280","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.bjp.0705040","article-title":"The role of the 8\u201318 helix of CGRP8\u201337 in mediating high affinity binding to CGRP receptors; coulombic and steric interactions","volume":"138","author":"Howitt","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0285","doi-asserted-by":"crossref","first-page":"S418","DOI":"10.1097\/00004872-198812040-00131","article-title":"The interaction of calcitonin gene-related peptide with angiotensin II on blood pressure and renin release","volume":"6","author":"Itabashi","year":"1988","journal-title":"J. Hypertens. Suppl."},{"key":"10.1016\/j.npep.2010.12.002_b0290","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.bbrc.2004.05.103","article-title":"Aspartate69of thecalcitonin-like receptoris required for its functional expression together withreceptor-activity-modifying proteins1 and -2","volume":"319","author":"Ittner","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.npep.2010.12.002_b0295","series-title":"Hypertension Primer: The Essentials of High Blood Pressure, Basic Science, population science and clinical management. 4th Edition","author":"Izzo","year":"2008"},{"key":"10.1016\/j.npep.2010.12.002_b0300","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.pain.2003.09.008","article-title":"NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release","volume":"106","author":"Juhasz","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.npep.2010.12.002_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/140174398427965","article-title":"Release and effects of calcitonin gene-related peptide in myocardial ischaemia","volume":"49","author":"Kallner","year":"1998","journal-title":"Scand. Cardiovasc. J. Suppl."},{"key":"10.1016\/j.npep.2010.12.002_b0310","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1254\/jjp.88.39","article-title":"Regulation of vascular function by perivascular calcitonin gene-related peptide-containing nerves","volume":"88","author":"Kawasaki","year":"2002","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0315","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1291\/hypres.21.235","article-title":"Reduction in blood pressure with a sodium-reduced, potassium- and magnesium-enriched mineral salt in subjects with mild essential hypertension","volume":"21","author":"Kawasaki","year":"1998","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.npep.2010.12.002_b0320","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/335164a0","article-title":"Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat","volume":"335","author":"Kawasaki","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.npep.2010.12.002_b0325","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.bjp.0707516","article-title":"The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?","volume":"153","author":"Kirkby","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0330","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1006\/bbrc.1993.1451","article-title":"Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma","volume":"192","author":"Kitamura","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.npep.2010.12.002_b0335","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1073\/pnas.82.15.5064","article-title":"Linkage map of the short arm of human chromosome 11: location of the genes for catalase, calcitonin, and insulin-like growth factor II","volume":"82","author":"Kittur","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.npep.2010.12.002_b0340","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0014-2999(87)90073-2","article-title":"Calcitonin gene-related peptide increases survival of a musculocutaneous critical flap in the rat","volume":"142","author":"Kjartansson","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0345","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.ki.5002303","article-title":"The endothelium-derived hyperpolarizing factor: insights from genetic animal models","volume":"72","author":"K\u00f6hler","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.npep.2010.12.002_b0350","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1291\/hypres.26.S105","article-title":"Targeted disruption of adrenomedullin and alphaCGRP genes reveals their distinct biological roles","volume":"26","author":"Kurihara","year":"2003","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.npep.2010.12.002_b0355","doi-asserted-by":"crossref","first-page":"22623","DOI":"10.1074\/jbc.M302571200","article-title":"Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity","volume":"278","author":"Kuwasako","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2010.12.002_b0360","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1196\/annals.1367.008","article-title":"Stress, visceral obesity, and metabolic complications","volume":"1083","author":"Kyrou","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.npep.2010.12.002_b0365","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s11906-007-0057-8","article-title":"Dietary salt restriction and blood pressure in clinical trials","volume":"9","author":"Lackland","year":"2007","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.npep.2010.12.002_b0745","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/00004872-199409000-00012","article-title":"Increased basal concentrations of plasma endothelin in borderline hypertension","volume":"12","author":"Lemne","year":"1994","journal-title":"J. Hypertens."},{"key":"10.1016\/j.npep.2010.12.002_b0370","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/HJH.0b013e328329bbd7","article-title":"Role of anandamide transporter in regulating calcitonin gene-related peptide production and blood pressure in hypertension","volume":"27","author":"Li","year":"2009","journal-title":"J. Hypertens."},{"key":"10.1016\/j.npep.2010.12.002_b0375","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.peptides.2008.06.010","article-title":"Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats","volume":"29","author":"Li","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2010.12.002_b0380","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/01.hjh.0000125409.50839.f1","article-title":"Activation of the renin-angiotensin system in \u03b1-calcitonin gene-related peptide\/calcitonin gene knockout mice","volume":"22","author":"Li","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.npep.2010.12.002_b0385","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1126\/science.1658940","article-title":"Expression cloning of an adenylate cyclase-coupled calcitonin receptor","volume":"254","author":"Lin","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.npep.2010.12.002_b0390","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.jhh.1001294","article-title":"Enhanced vasodilator responses to calcitonin gene-related peptode (CGRP) in subcutaneous arteries in human hypertension","volume":"16","author":"Lind","year":"2002","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.npep.2010.12.002_b0395","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1475-097X.1996.tb00557.x","article-title":"Different levels of sensory neuropeptides (calcitonin gene-related peptide and substance P) during and after exercise in man","volume":"16","author":"Lind","year":"1996","journal-title":"Clin. Physiol."},{"key":"10.1016\/j.npep.2010.12.002_b0400","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/08037050600996586","article-title":"Reduced responsiveness of cutaneous microcirculation in essential hypertension-a pilot study","volume":"15","author":"Lindstedt","year":"2006","journal-title":"Blood Press."},{"key":"10.1016\/j.npep.2010.12.002_b0405","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/mcne.1999.0767","article-title":"Mice lacking alpha-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development","volume":"14","author":"Lu","year":"1999","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.npep.2010.12.002_b0410","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0014-2999(85)90456-X","article-title":"Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin","volume":"108","author":"Lundberg","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0415","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1474-8673.1991.tb00317.x","article-title":"The pharmacology of the efferent function of sensory nerves","volume":"11","author":"Maggi","year":"1991","journal-title":"J. Auton. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0420","first-page":"157","article-title":"Capsaicin-sensitive nerves in the gastrointestinal tract","volume":"303","author":"Maggi","year":"1990","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.npep.2010.12.002_b0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-3623(88)90002-X","article-title":"The sensory-efferent function of capsaicin-sensitive sensory neurons","volume":"19","author":"Maggi","year":"1988","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0430","doi-asserted-by":"crossref","first-page":"14294","DOI":"10.1074\/jbc.M109661200","article-title":"Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists","volume":"277","author":"Mallee","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2010.12.002_b0435","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.mcna.2009.02.014","article-title":"The renin angiotensin aldosterone system in hypertension:role of insulin resistance and oxidative stress","volume":"93","author":"Manrique","year":"2009","journal-title":"The Medical Clinics of North America"},{"key":"10.1016\/j.npep.2010.12.002_b0440","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0167-0115(88)90339-4","article-title":"Enhanced development of deoxycorticosterone-induced hypertension in neonatally capsaicin-pretreated rats","volume":"22","author":"Manzini","year":"1988","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2010.12.002_b0445","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF03165805","article-title":"Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension","volume":"62","author":"M\u00e1rquez-Rodas","year":"2006","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.npep.2010.12.002_b0450","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/00004872-199210120-00010","article-title":"Plasma calcitonin gene-related peptide levels in patients with various hypertensive diseases","volume":"10","author":"Masuda","year":"1992","journal-title":"J. Hypertens."},{"key":"10.1016\/j.npep.2010.12.002_b0455","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin- receptor-like receptor","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.npep.2010.12.002_b0460","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/jpet.109.155143","article-title":"Calcitonin gene-related peptide selectively relaxes contractile responses to endothelin-1 in rat mesenteric resistance arteries","volume":"331","author":"Meens","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2010.12.002_b0465","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0090-6980(76)90014-9","article-title":"Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition","volume":"12","author":"Moncada","year":"1976","journal-title":"Prostaglandins"},{"key":"10.1016\/j.npep.2010.12.002_b0470","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0306-4522(88)90018-8","article-title":"Differential expression of alpha-CGRP and beta-CGRP by primary sensory neurons and enteric autonomic neurons of the rat","volume":"25","author":"Mulderry","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2010.12.002_b0475","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1152\/physrev.1990.70.4.921","article-title":"Structure and function of small arteries","volume":"70","author":"Mulvany","year":"1990","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.npep.2010.12.002_b0480","series-title":"National Collaborating Centre for Chronic Conditions. Hypertension: management of hypertension in adults in primary care: partial update of NICE Clinical Guideline 18, number 34. 34.","year":"2006"},{"key":"10.1016\/j.npep.2010.12.002_b0485","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/344770a0","article-title":"Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels","volume":"344","author":"Nelson","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.npep.2010.12.002_b0490","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/hh2301.100812","article-title":"Elevated sympathetic nervous activity in mice deficient in alphaCGRP","volume":"89","author":"Oh-hashi","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.npep.2010.12.002_b0495","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa030505","article-title":"Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine","volume":"350","author":"Olesen","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.npep.2010.12.002_b0500","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00004647-200205000-00014","article-title":"Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature","volume":"22","author":"Oliver","year":"2002","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.npep.2010.12.002_b0505","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-139-9-200311040-00011","article-title":"Pathogenesis of hypertension","volume":"139","author":"Oparil","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.npep.2010.12.002_b0510","first-page":"1","article-title":"Dual ET(A)\/ET(B) vs","volume":"36","author":"Opitz","year":"2006","journal-title":"Selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension. Eur. J. Clin. Invest."},{"key":"10.1016\/j.npep.2010.12.002_b0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2009.10.053","article-title":"The vanilloid receptor TRPV1: role in cardiovascular and gastrointestinal protection","volume":"10","author":"Peng","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0520","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0021-9258(19)75816-5","article-title":"Identification in the human central nervous system, pituitary, and thyroid of a novel calcitonin gene-related peptide, and partial amino acid sequence in the spinal cord","volume":"262","author":"Petermann","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2010.12.002_b0525","first-page":"453","article-title":"Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors","volume":"5","author":"Pimenta","year":"2009","journal-title":"Vascular Health and Risk Management"},{"key":"10.1016\/j.npep.2010.12.002_b0535","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/07420529309073886","article-title":"Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach","volume":"10","author":"Portaluppi","year":"1993","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.npep.2010.12.002_b0540","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00004872-199210000-00017","article-title":"Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension","volume":"10","author":"Portaluppi","year":"1992","journal-title":"J. Hypertens."},{"key":"10.1016\/j.npep.2010.12.002_b0545","first-page":"233","article-title":"International Union of Pharmacology:XXXII","volume":"54","author":"Poyner","year":"2002","journal-title":"The mammalian calcitonin gene-related peptides, AM, AMY, and calcitonin receptors. Pharmacol. Rev."},{"key":"10.1016\/j.npep.2010.12.002_b0550","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ajh\/6.5.434","article-title":"Calcitonin gene-related peptide and regulation of human cardiovascular homeostasis","volume":"6","author":"Preibisz","year":"1993","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.npep.2010.12.002_b0555","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1476-5381.2009.00541.x","article-title":"Structure-function relationships of the N-terminus of receptor activity-modifying proteins","volume":"159","author":"Qi","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0560","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1749-6632.1992.tb22759.x","article-title":"Characterization of CGRP1 and CGRP 2 receptor subtypes","volume":"657","author":"Quirion","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.npep.2010.12.002_b0565","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1124\/jpet.108.144220","article-title":"Calcitonin gene-related peptide receptor antagonism does not affect the severity of myocardial ischaemia during atrial pacing in dogs with coronary artery stenosis","volume":"328","author":"Regan","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2010.12.002_b0570","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1074\/jbc.M305332200","article-title":"Intermedin is a calcitonin\/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor\/receptor activity-modifying protein receptor complexes","volume":"279","author":"Roh","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.npep.2010.12.002_b0575","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0196-9781(92)90067-D","article-title":"CGRP antagonist activity of short C-terminal fragments of human alpha CGRP, CGRP(23\u201337) and CGRP(19\u201337)","volume":"13","author":"Rovero","year":"1992","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2010.12.002_b0580","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2217\/14622416.8.7.687","article-title":"Ramping it up: RAMP1 and the implications for migraine","volume":"8","author":"Russo","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.npep.2010.12.002_b0585","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/HYPERTENSIONAHA.109.148171","article-title":"Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates Angiotensin-induced hypertension","volume":"55","author":"Sabharwal","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.npep.2010.12.002_b0590","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ajh\/4.7.565","article-title":"Normal serum levels of calcitonin gene-related peptide (CGRP) in mild to moderate essential hypertension","volume":"4","author":"Schifter","year":"1991","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.npep.2010.12.002_b0595","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1152\/ajprenal.00280.2006","article-title":"Attenuated vasoconstrictor responses to endothelin in afferent arterioles during a high-salt diet","volume":"292","author":"Schneider","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.npep.2010.12.002_b0600","first-page":"413","article-title":"Modulating receptor function through RAMPs:can they represent drug targets in themselves? Drug Discov","volume":"14","author":"Sexton","year":"2009","journal-title":"Today"},{"key":"10.1016\/j.npep.2010.12.002_b0605","first-page":"11398","article-title":"Structure function analysis of RAMP1 by alanine mutagenesis","volume":"41","author":"Simms","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.npep.2010.12.002_b0610","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0014-5793(86)81091-2","article-title":"Structure and expression of the human calcitonin\/CGRP genes","volume":"209","author":"Steenbergh","year":"1986","journal-title":"FEBS Lett."},{"key":"10.1016\/j.npep.2010.12.002_b0615","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0014-5793(03)01250-X","article-title":"The function of conserved cysteine residues in the extracellular domain of human receptor-activity-modifying protein","volume":"555","author":"Steiner","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.npep.2010.12.002_b0620","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1021\/bi020279r","article-title":"The transmembrane domain of receptor-activity-modifying protein 1 is essential for the functional expression of a calcitonin gene-related peptide receptor","volume":"41","author":"Steiner","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.npep.2010.12.002_b0625","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/01.HYP.29.4.945","article-title":"Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hypertension in the rat","volume":"29","author":"Supowit","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.npep.2010.12.002_b0630","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ncpcardio1091","article-title":"The aging hypertensive heart: a brief update","volume":"5","author":"Susic","year":"2008","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.npep.2010.12.002_b0635","first-page":"897","article-title":"Calcitonin gene-related peptide in the pathogenesis and treatment of hypertension","volume":"102","author":"Tang","year":"1989","journal-title":"Chin. Med. J. (Engl)."},{"key":"10.1016\/j.npep.2010.12.002_b0640","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/HYPERTENSIONAHA.107.090084","article-title":"Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects","volume":"50","author":"Tatasciore","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.npep.2010.12.002_b0645","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0304-3940(94)90615-7","article-title":"Neonatal capsaicin treatment in rats results in scratching behavior with skin damage: potential model of non-painful dysesthesia","volume":"171","author":"Thomas","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2010.12.002_b0650","doi-asserted-by":"crossref","first-page":"16702","DOI":"10.1073\/pnas.0705974104","article-title":"Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice","volume":"104","author":"Tsujikawa","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.npep.2010.12.002_b0655","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12199-008-0040-2","article-title":"Association of hypertension with changes in the body mass index of university students","volume":"13","author":"Uchiyamam","year":"2008","journal-title":"Environ. Health. Prev. Med."},{"key":"10.1016\/j.npep.2010.12.002_b0660","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1124\/mol.106.024257","article-title":"A critical role for the short intracellular C terminus in receptor activity-modifying protein function","volume":"70","author":"Udawela","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-0115(86)90071-6","article-title":"Calcitonin gene-related peptide (CGRP); perivascular distribution and vasodilatory effects","volume":"15","author":"Uddman","year":"1986","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2010.12.002_b0670","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/cvr\/27.8.1477","article-title":"Effect of intravenous calcitonin gene related peptide on ischaemia threshold and coronary stenosis severity in humans","volume":"27","author":"Uren","year":"1993","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.npep.2010.12.002_b0675","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(02)00221-7","article-title":"Production and secretion of calcitonin gene-related peptide from human lymphocytes","volume":"130","author":"Wang","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.npep.2010.12.002_b0680","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1745-7254.2005.00057.x","article-title":"The vanilloid receptor and hypertension","volume":"26","author":"Wang","year":"2005","journal-title":"Acta. Pharmacol. Sin."},{"key":"10.1016\/j.npep.2010.12.002_b0685","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11655-001-0287-6","article-title":"Effects of Qindan Capsule on blood pressure, endothelin, calcitonin gene-related peptide and angiotensin- II in spontaneous hypertensive rats","volume":"12","author":"Wang","year":"2006","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.npep.2010.12.002_b0690","first-page":"719","article-title":"Increased plasma vasoactive substances and antioxidant enzymes levels in prehypertensive patients","volume":"35","author":"Wang","year":"2007","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi."},{"key":"10.1016\/j.npep.2010.12.002_b0695","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-291X(86)90708-4","article-title":"A novel peptide in the calcitonin gene relate peptide family as an ahyloid fibril protein in the endocrine pancrrab","volume":"140","author":"Westermark","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.npep.2010.12.002_b0700","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.jhh.1001683","article-title":"Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society","volume":"18","author":"Williams","year":"2004","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.npep.2010.12.002_b0705","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0006-291X(90)90621-S","article-title":"Isolation, purification and characterization of beta-hCGRP from human spinal cord","volume":"167","author":"Wimalawansa","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.npep.2010.12.002_b0710","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1210\/edrv-17-5-533","article-title":"Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potential","volume":"17","author":"Wimalawansa","year":"1996","journal-title":"Endoc. Rev."},{"key":"10.1016\/j.npep.2010.12.002_b0715","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.2174\/1381612043382855","article-title":"Pathophysiology and treatment of obesity hypertension","volume":"10","author":"Wofford","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.npep.2010.12.002_b0720","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0014-2999(00)00407-6","article-title":"Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et)(2, 7)]hCGRP-preferring receptor","volume":"400","author":"Wu","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2010.12.002_b0725","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0378-5122(98)00047-4","article-title":"Postmenopausal women with vasomotor symptoms have increased urinary excretion of calcitonin gene-related peptide","volume":"30","author":"Wyon","year":"1998","journal-title":"Maturitas"},{"key":"10.1016\/j.npep.2010.12.002_b0730","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/01.RES.53.2.121","article-title":"Peripheral neurogenic factors in acute and chronic alterations of arterial pressure","volume":"53","author":"Zimmerman","year":"1983","journal-title":"Circ. Res."},{"key":"10.1016\/j.npep.2010.12.002_b0735","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1006\/bbrc.1999.1943","article-title":"Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product","volume":"267","author":"Zumpe","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417910001150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417910001150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T05:36:32Z","timestamp":1740893792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417910001150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":148,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0143417910001150"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2010.12.002","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}